Copyright © 2014 Vanita Noronha et al.This is an open access article distributed under theCreative CommonsAttribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction. Brain metastasis is a poor prognostic marker in lung cancer. However it is not known whether amongst patients with EGFR mutation those with brain metastases have a worse outcome. Methods. We compared the survival outcomes between EGFR mutation positive patients with and without brain metastases. In this retrospective analysis of prospective database of all metastatic lung cancer patients at our centre between July 2009 and December 2012, patients were treated with either combinati...
Approximately half of all patients with non-small cell lung cancer (NSCLC) develop central nervous s...
The brain represents a frequent progression site in lung adenocarcinoma. This study was designed to ...
<div><p>Previous studies have demonstrated the association between EGFR mutations and distant metast...
Introduction. Brain metastasis is a poor prognostic marker in lung cancer. However it is not known w...
Abstract Background The brain is a common site for metastasis in non-small-cell lung cancer (NSCLC)....
International audienceBackground: Lung cancer is the leading cause of brain metastases (BM). The ide...
ObjectivesThe purpose of this study was to examine the impact of epidermal growth factor receptor (E...
Yun Fan,1,2 Xiaoling Xu,3 Conghua Xie4 1Zhongnan Hospital of Wuhan University, Department of Radiati...
Objective: While several prognostic models have been presented in NSCLC patients with brain metastas...
Background: Brain metastases (BM) from non-small-cell lung cancer (NSCLC) are frequent and carry sig...
ObjectivesThe purpose of this study was to examine the impact of epidermal growth factor receptor (E...
Haiyang Wang,1,* Xiaoqing Yu,1,* Yun Fan,2 Youhua Jiang2 1Department of Second Clinical Medical Col...
Introduction: Nonsmall cell lung cancer (NSCLC) is the leading cause of cancer-related deaths in man...
Background: Radiotherapy and surgery are the standard local treatments for lung cancer brain metasta...
BackgroundTreatment paradigms for metastatic non-small cell lung cancer are increasingly based on bi...
Approximately half of all patients with non-small cell lung cancer (NSCLC) develop central nervous s...
The brain represents a frequent progression site in lung adenocarcinoma. This study was designed to ...
<div><p>Previous studies have demonstrated the association between EGFR mutations and distant metast...
Introduction. Brain metastasis is a poor prognostic marker in lung cancer. However it is not known w...
Abstract Background The brain is a common site for metastasis in non-small-cell lung cancer (NSCLC)....
International audienceBackground: Lung cancer is the leading cause of brain metastases (BM). The ide...
ObjectivesThe purpose of this study was to examine the impact of epidermal growth factor receptor (E...
Yun Fan,1,2 Xiaoling Xu,3 Conghua Xie4 1Zhongnan Hospital of Wuhan University, Department of Radiati...
Objective: While several prognostic models have been presented in NSCLC patients with brain metastas...
Background: Brain metastases (BM) from non-small-cell lung cancer (NSCLC) are frequent and carry sig...
ObjectivesThe purpose of this study was to examine the impact of epidermal growth factor receptor (E...
Haiyang Wang,1,* Xiaoqing Yu,1,* Yun Fan,2 Youhua Jiang2 1Department of Second Clinical Medical Col...
Introduction: Nonsmall cell lung cancer (NSCLC) is the leading cause of cancer-related deaths in man...
Background: Radiotherapy and surgery are the standard local treatments for lung cancer brain metasta...
BackgroundTreatment paradigms for metastatic non-small cell lung cancer are increasingly based on bi...
Approximately half of all patients with non-small cell lung cancer (NSCLC) develop central nervous s...
The brain represents a frequent progression site in lung adenocarcinoma. This study was designed to ...
<div><p>Previous studies have demonstrated the association between EGFR mutations and distant metast...